We highlight its potential mechanisms of action, including suppression of inflammation and oxidative stress, inhibition of TGF-β1–mediated renal fibrosis, protection of podocyte function, and induction of ferroptosis, and discuss the possible synergistic interactions among these effects in modulating the DN disease network. The gene discussed is TGFB1; the disease is renal fibrosis.